A study showing the efficacy of the Intracept procedure developed by medical device company Relievant Medsystems, which develops minimally invasive solutions for low-back pain, was published in the International Journal of Spine Surgery.
The study involved a Level I SMART trial for low-back pain, which compared the Intracept procedure to a placebo procedure over 24 months.
Three notable results of the trial:
1. Opioid use was eliminated in 46.4 percent of patients who took opioids at baseline.
2. The number of patients receiving spinal injections for pain was reduced from 57.5 percent to 7.5 percent two years after treatment.
3. The researchers reported no related serious adverse events.
Read the full study here.